Ovarian cyst formation in patients using tamoxifen for breast cancer

Japanese Journal of Clinical Oncology

Volumn 35, Issue 10, 2005, Pages 607-611

  Metindir, Jale ^a,b   Aslan, Sabahattin ^a   Bilir, Gülay ^a  

^a ANKARA ONCOLOGY HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Breast cancer; Estradiol; Follicle stimulating hormone; Ovarian cysts; Tamoxifen

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTRADIOL; FLUOROURACIL; FOLLITROPIN; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; AMENORRHEA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RISK; CONTROLLED STUDY; DISEASE DURATION; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MENSTRUAL CYCLE; MULTIVARIATE ANALYSIS; OVARY CYST; POSTMENOPAUSE; PREMENOPAUSE; RETROSPECTIVE STUDY; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; AMENORRHEA; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MIDDLE AGED; OVARIAN CYSTS; POSTMENOPAUSE; PREMENOPAUSE; RETROSPECTIVE STUDIES; TAMOXIFEN;

EID: 27944493623     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyi165     Document Type: Review

References (35)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992;339:1-15.
2. Sunderland MC, Osborne CK. Tamoxifen in premenopausal patients with metastatic breast cancer: A review. J Clin Oncol 1991;9:1283-97.
3. Goldrisch A, Gelber RD, Castiglione M, for the International Breast Cancer Study Group. Adjuvant therapy of breast cancer. Eur J Cancer 1991;27:399-402.
4. Powles TJ, Tillyer CR, Jones AL. Prevention of breast cancer with tamoxifen - an update on the Royal Marsden Hospital Pilot Programme. Eur J Cancer 1990;26:680-4.
5. Fentiman IS, Powles TJ. Tamoxifen and benign breast problems. Lancet 1987;2:1010-7.
6. Weseley AC, Melnick H. Tamoxifen in clomiphene-resistant hypothalamic anovulation. Int J Fertil 1987;32:226-8.
7. Spinelli G, Bardozzi N, Citernessi A, Fontonarosa M, Curiel P. Endometrial carcinoma in tamoxifen treated cancer patients. J Chemother 1991; 3:267-70.
8. Gorodeski GI, Beery R, Lunenfeld B, Geier A. Tamoxifen increases plasma estrogen-binding equivalents and has an estradiol agonistic effect on histologically normal premenopausal and post menopausal endometrium. Fertil Steril 1992;57:320-7.
9. Jordan VC, Hoerner S. Tamoxifen and the human carcinoma 8S estrogen receptor. Eur J Cancer 1975;11:205-6.
10. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992;339:71-85.
11. Fornander T, Cedermark B, Mattson A, Skoog L, Theve T, Askergren J, et al. Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1989;1:117-20.
12. Hardell L. Tamoxifen as a factor for carcinoma of corpus uteri. Lancet 1988;3:563.
13. Jolles CJ, Smotkin D, Ford KL, Jones KP. Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a premenopausal woman: A case report. J Reprod Med 1990;35:299-300.
14. Barbieri RL, Ferracci AL, Droesch JN, Rochelson BL. Ovarian torsion in a premenopausal woman treated for breast cancer. Fertil Steril 1993;59: 459-60.
15. Seoud MAF, Johnson J, Weed JC. Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 1993;82:165-9.
16. Terada S, Uchide K, Suzuki N, Akasofu K. A follicular cyst during tamoxifen therapy in a premenopausal breast cancer women. Gynecol Obstet Invest 1993;35:62-4.
17. Cohen I, Rosen DJD, Altaras MM, Beyth Y, Shapira J, Yigael D. Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian over-stimulation, cystic formations and fibroid overgrowth. Br J Cancer 1994;69:620-1.
18. Shulman A, Cohen I, Altaras MM, Maymon R, Ben-Nun I, Tepper R, Beyth Y. Ovarian cyst formation in two premenopausal patients treated with tamoxifen for breast cancer. Hum Reprod 1994;9: 1427-9.
19. Powles TJ, Jones AL, Ashley SE, O'Brien MER, Tidy VA, Treleaven J, et al. The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat 1994;31:73-82.
20. Boccardo F, Rubagotti A, Amoroso D, Sismondi P, Genta F, Nenci I, et al. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-hormone Therapy Cooperative Group) Trial. Eur J Cancer 1992;28:673-80.
21. Cohen I, Beyth Y, Tepper R, Shapira J, Zalel Y, Figer A, et al. Ovarian tumors in postmenopausal breast cancer patients treated with tamoxifen. Gynecol Oncol 1996;60:54-8.
22. Shushan A, Peretz T, Uziely B, Lewin A, Mor-Yosef S. Ovarian cysts in premenopausal tamoxifen treated women with breast cancer. Am J Obstet Gynecol 1996;174:141-4.
23. Mourits MJ, de Vries EG, Willemse PH, ten Hoor KA, Hollema H, Sluiter WJ, et al. Ovarian cysts in women receiving tamoxifen for breast cancer. Br J Cancer 1999;79:1761-4.
24. Radvin PM, Fritz NF, Tormey DC, Jordan VC. Endocrine status of premenopausal node positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen. Cancer Res 1998;46:1026-9.
25. Spicer DV, Pike MC, Henderson BE. Ovarian cancer and long-term tamoxifen in premenopausal women. Lancet 1991;337:1414.
26. Sherman BM, Chapler FK, Crickard K, Wycoff D. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. J Clin Invest 1979;64:398-404.
27. Speroff L, Glass RH, Kase NG. Regulation of the menstrual cycle. In: Mitchell, editor. Clinical Gynecologic Endocrinology and Infertility, 5th edn. Baltimore: Williams and Wilkins 1994; 183-230.
28. Granberg S, Wikland M, Jansson I. Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: Criteria to be used for ultrasound evaluation. Gynecol Oncol 1989;35:139-44.
29. Manni A, Pearson OH. Antiestrogen-induced remission in premenopausal women with stage IV breast cancer: Effects on ovarian function. Cancer Treat Rep 1980;64:779-85.
30. Ludwig Breast Cancer Study Group. A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. Cancer Res 1985;45:4454-9.
31. Elkas J, Gray K, Howard L, Petit N. The effects of tamoxifen on endometrial insulin-like growth factor-1 expression. Obstet Gynecol 1998;91:45-50.
32. Cohen I, Figer A, Tepper R, Shapira J, Altaras MM, Yigael D, Beyth Y. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: Comparison between tamoxifen-treated and nontreated breast cancer patients. Gynecol Oncol 1999;72:202-7.
33. Hartge P, Schiffman MH, Hoover R, McGowan L, Lesher L, Norris HJ. A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol 1989;161:10-6.
34. Seoud M, El-saghir N, Salem Z, Shamseddine A, Awward J, Medawar W, Khalil A. Tamoxifen and ovarian cysts: A prospective study. Eur J Obstet Gynecol Reprod Biol 2001;100:77-80.
35. Christensen JT, Boldsen JL, Westergaard JG. Functional ovarian cysts in premenopausal and gynecologically healthy women. Contraception 2002;66:153-7.